About
World Health Organization reported that around 17.9 million people died from heart diseases in 2019. JENDO's vision is to reduce the global death count resulted from cardiovascular diseases such as heart attacks, diabetes, cholesterol and kidney failures and reduce the financial burden on healthcare systems, by early detection and following an preventive approach, increasing overall cardiovascular wellbeing. JENDO was granted a U.S. Patent for the Signal Capturing Device, Cloud based Machine Learning and AI capabilities and the methodology from United States Patent and Trademark Office (US 10, 912, 464 B2).
Technologies
GmailGoogle AppsRemote
Keywords
medical equipment manufacturinguser experiencehealthtechpredictive health analyticshealthcare analyticsd2chipaa compliancehealthcareendothelial change detectionpredictive analyticsregulatory compliancethermal sensorsscalable healthcare systemlifestyle advice platformtelemedicinedata securityearly diagnosis of cvdhealthcare softwareremote patient monitoringcardiovascular disease preventioncardiovascular healthppg sensorsproprietary algorithmb2crisk assessmentlifestyle recommendationsmedical devicesblood vessel innermost layer assessmentnon-invasive monitoringsensor technology
Company Information
- Employees6
- Founded2016
Location
De Fonseka Place, Colombo, Western Province, Sri Lanka, 04
